TORIPALIMAB-TPZI

TORIPALIMAB-TPZI was reported 43 times

TORIPALIMAB-TPZI is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PNEUMONITIS ASPIRATION 3 0.0088
1 AUTOIMMUNE MYOSITIS 2 0.0042
2 WOUND DRAINAGE 1 0.0013
3 BLOOD CALCIUM ABNORMAL 1 0.0006
4 TREATMENT DELAYED 1 0.0006
5 PARAPLEGIA 1 0.0003
6 DISEASE COMPLICATION 1 0.0002
7 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
8 RESPIRATORY DISTRESS 3 0.0001
9 HOSPICE CARE 1 0.0001
10 BREAST CANCER METASTATIC 1 0.0001
11 PARALYSIS 1 0.0001
12 SKIN FISSURES 1 0.0001
13 HEPATITIS 1 0.0000
14 LABORATORY TEST ABNORMAL 1 0.0000
15 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
16 NEUTROPENIA 4 0.0000
17 OFF LABEL USE 25 0.0000
18 NEUTROPHIL COUNT DECREASED 1 0.0000
19 PRODUCTIVE COUGH 1 0.0000
20 HOSPITALISATION 3 0.0000
21 INFLAMMATION 1 0.0000
22 ECZEMA 1 0.0000
23 MUSCULOSKELETAL PAIN 1 0.0000
24 DERMATITIS ATOPIC 1 0.0000
25 LETHARGY 1 0.0000
26 BLOOD PRESSURE DECREASED 1 0.0000
27 MOBILITY DECREASED 1 0.0000
28 INJECTION SITE HAEMORRHAGE 1 0.0000
29 ADVERSE DRUG REACTION 1 0.0000
30 HEART RATE INCREASED 1 0.0000
31 HAEMORRHAGE 1 0.0000
32 SEPSIS 1 0.0000
33 DEATH 6 0.0000
34 ACUTE KIDNEY INJURY 1 0.0000
35 HYPERSENSITIVITY 1 0.0000
36 HYPERTENSION 1 0.0000
37 CONSTIPATION 1 0.0000
38 ABDOMINAL PAIN 1 0.0000
39 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
40 FATIGUE 3 0.0000
41 WEIGHT DECREASED 1 0.0000
42 CONDITION AGGRAVATED 1 0.0000
43 PRURITUS 1 0.0000
44 RASH 1 0.0000